KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xylem (XYL) EPS (Weighted Average and Diluted) (2016 - 2026)

Xylem has reported EPS (Weighted Average and Diluted) over the past 17 years, most recently at $0.79 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 14.49% year-over-year to $0.79; the TTM value through Mar 2026 reached $4.02, up 8.36%, while the annual FY2025 figure was $3.92, 7.4% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $0.79 at Xylem, down from $1.37 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $1.37 in Q4 2025 and troughed at $0.07 in Q3 2022.
  • A 5-year average of $0.77 and a median of $0.79 in 2026 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 88.89% in 2022 and later surged 800.0% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.82 in 2022, then skyrocketed by 41.46% to $1.16 in 2023, then grew by 14.66% to $1.33 in 2024, then grew by 3.01% to $1.37 in 2025, then tumbled by 42.34% to $0.79 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for XYL at $0.79 in Q1 2026, $1.37 in Q4 2025, and $0.93 in Q3 2025.